This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Mithra Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €1.171. Mithra Pharmaceuticals's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is €0.00.
As of today (2024-04-23), Mithra Pharmaceuticals's share price is €2.955. Mithra Pharmaceuticals's Median PS Value is €0.00. Therefore, Mithra Pharmaceuticals's Price to Median PS Value for today is 0.00.
The historical rank and industry rank for Mithra Pharmaceuticals's Median PS Value or its related term are showing as below:
CHIX:MITRAb's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.78 * Ranked among companies with meaningful Price-to-Median-PS-Value only.
Mithra Pharmaceuticals Median PS Value Historical Data
The historical data trend for Mithra Pharmaceuticals's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mithra Pharmaceuticals's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mithra Pharmaceuticals Price-to-Median-PS-Value Distribution
For the Drug Manufacturers industry and Healthcare sector, Mithra Pharmaceuticals's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Mithra Pharmaceuticals's Price-to-Median-PS-Value falls into.
Mithra Pharmaceuticals Median PS Value Calculation
Mithra Pharmaceuticals's Median PS Value for today is calculated as
10-Year Median PS Ratio is 0.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Mithra Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 was €1.171.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mithra Pharmaceuticals (CHIX:MITRAb) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Mithra Pharmaceuticals's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
2.955
/
0.00
=
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mithra Pharmaceuticals Median PS Value Related Terms
Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Mithra Pharmaceuticals (CHIX:MITRAB) Business Description
Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CHIX:MITRAB has been successfully added to your 